Trial Profile
Phase II trial of Intercell's Japanese encephalitis vaccine, IC 51, compared with a mouse-brain Japanese encephalitis vaccine, for the prevention of encephalitis virus infections in paediatric patients in India.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2009
Price :
$35
*
At a glance
- Drugs IC 51 (Primary) ; Aluminium hydroxide; Japanese encephalitis vaccine
- Indications Encephalitis virus infections; Japanese encephalitis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Biological E Limited; Intercell
- 08 Jan 2010 Results reported in Vaccine.
- 10 Dec 2008 Results data presented at the American Society for Tropical Medicine and Hygiene Annual Meeting (ASTMH) 2008, as reported in a media release from Intercell.
- 15 Apr 2008 Preliminary results available, according to an Intercell media release.